Denis Drygin

Denis Drygin

Company: Regulus Therapeutics

Job title: CSO


Lessons Learned from Pre-Clinical & Clinical Development of MicroRNA Therapeutics 12:30 pm

Improving screening cascade to mitigate potential off-target effects Harnessing the pleotropic nature of microRNAs Future directionsRead more

day: Day Two

Breakfast Panel: What does the Future Landscape of Emerging Non-Coding RNA Therapeutics Look Like?

Ranjan Perera
Director RNA Center & Associate Professor, Johns Hopkins University

9:00 am

What are considered as emerging non-coding RNA therapeutics and where is innovation expected to come from? Outlining the advantages and opportunities that emerging long non-coding RNA therapeutics and microRNAs offer Discussing what the next steps are in the research to accelerate these novel therapeutics into the clinicRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.